» Articles » PMID: 22392620

Simultaneous Screening of Glutathione and Cyanide Adducts Using Precursor Ion and Neutral Loss Scans-dependent Product Ion Spectral Acquisition and Data Mining Tools

Overview
Specialty Chemistry
Date 2012 Mar 7
PMID 22392620
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Drugs can be metabolically activated to soft and hard electrophiles, which are readily trapped by glutathione (GSH) and cyanide (CN), respectively. These adducts are often detected and structurally characterized using separate tandem mass spectrometry methods. We describe a new method for simultaneous screening of GSH and CN adducts using precursor ion (PI) and neutral loss (NL) scans-dependent product ion spectral acquisition and data mining tools on an triple quadrupole linear ion trap mass spectrometry. GSH, potassium cyanide, and their stable isotope labeled analogues were incubated with liver microsomes and a test compound. Negative PI scan of m/z 272 for detection of GSH adducts and positive NL scans of 27 and 29 Da for detection of CN adducts were conducted as survey scans to trigger acquisition of enhanced resolution (ER) spectrum and subsequent enhanced product ion (EPI) spectrum. Post-acquisition data mining of EPI data set using NL filters of 129 and 27 Da was then performed to reveal the GSH adducts and CN adducts, respectively. Isotope patterns and EPI spectra of the detected adducts were utilized for identification of their molecular weights and structures. The effectiveness of this method was evaluated by analyzing reactive metabolites of nefazodone formed from rat liver microsomes. In addition to known GSH- and CN-trapped reactive metabolites, several new CN adducts of nefazodone were identified. The results suggested that current approach is highly effective in the analysis of both soft and hard reactive metabolites and can be used as a high-throughput method in drug discovery.

Citing Articles

In Vitro Metabolism of Donepezil in Liver Microsomes Using Non-Targeted Metabolomics.

Kim S, Seo H, Jeong Y, Lee G, Ji S, Park S Pharmaceutics. 2021; 13(7).

PMID: 34201744 PMC: 8309179. DOI: 10.3390/pharmaceutics13070936.


The Metabolic Rainbow: Deep Learning Phase I Metabolism in Five Colors.

Dang N, Matlock M, Hughes T, Swamidass S J Chem Inf Model. 2020; 60(3):1146-1164.

PMID: 32040319 PMC: 8716320. DOI: 10.1021/acs.jcim.9b00836.


Identification of Azoxystrobin Glutathione Conjugate Metabolites in Maize Roots by LC-MS.

Dionisio G, Gautam M, Fomsgaard I Molecules. 2019; 24(13).

PMID: 31284429 PMC: 6651014. DOI: 10.3390/molecules24132473.


The busulfan metabolite EdAG irreversibly glutathionylates glutaredoxins.

Scian M, Atkins W Arch Biochem Biophys. 2015; 583:96-104.

PMID: 26278353 PMC: 4575911. DOI: 10.1016/j.abb.2015.08.005.


A generic multiple reaction monitoring based approach for plant flavonoids profiling using a triple quadrupole linear ion trap mass spectrometry.

Yan Z, Lin G, Ye Y, Wang Y, Yan R J Am Soc Mass Spectrom. 2014; 25(6):955-65.

PMID: 24692044 DOI: 10.1007/s13361-014-0863-6.

References
1.
Yan Z, Caldwell G . Stable-isotope trapping and high-throughput screenings of reactive metabolites using the isotope MS signature. Anal Chem. 2004; 76(23):6835-47. DOI: 10.1021/ac040159k. View

2.
LeBlanc A, Shiao T, Roy R, Sleno L . Improved detection of reactive metabolites with a bromine-containing glutathione analog using mass defect and isotope pattern matching. Rapid Commun Mass Spectrom. 2010; 24(9):1241-50. DOI: 10.1002/rcm.4507. View

3.
Zhang Z, Chen Q, Li Y, Doss G, Dean B, Ngui J . In vitro bioactivation of dihydrobenzoxathiin selective estrogen receptor modulators by cytochrome P450 3A4 in human liver microsomes: formation of reactive iminium and quinone type metabolites. Chem Res Toxicol. 2005; 18(4):675-85. DOI: 10.1021/tx0496789. View

4.
Dieckhaus C, Fernandez-Metzler C, King R, Krolikowski P, Baillie T . Negative ion tandem mass spectrometry for the detection of glutathione conjugates. Chem Res Toxicol. 2005; 18(4):630-8. DOI: 10.1021/tx049741u. View

5.
Zhuo X, Hartz R, Bronson J, Wong H, Ahuja V, Vrudhula V . Comparative biotransformation of pyrazinone-containing corticotropin-releasing factor receptor-1 antagonists: minimizing the reactive metabolite formation. Drug Metab Dispos. 2009; 38(1):5-15. DOI: 10.1124/dmd.109.028910. View